Funded by the European Union under the Horizon Europe Programme, Grant No. 101082304 (BlueRemediomics). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the granting authority, the Research Executive Agency (REA). Neither the European Union nor the granting authority can be held responsible for them.
UK Partners on BlueRemediomics are supported by UK Research and Innovation (UKRI) under the UK Government’s Horizon Europe funding guarantee Grant No. IFS 10061678 (University College London); IFS 10055633 (The Chancellors Masters and Scholars of the University of Cambridge); IFS 10057167 (University of Aberdeen).
The Swiss Partner (Eidgenoessische Technische Hochschule Zuerich) on BlueRemediomics has received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI) under Contract No. 22.00384.